 Mutated Genes and Abnormal Protein Expression
|
| Gene | Location | Topics
|
| BCL10 (
CLAP
, CIPER
)
| 1p22
|
-BCL10 Point Mutations in Hepatocellular Carcinoma
|
| PAP | 2p12
|
-PAP Expression in Hepatocarcinoma
|
| LCO | 2q14-q21
|
-LCO and Liver Cancer
|
| CTNNB1 (
CTNNB
)
| 3p22-p21.3
|
-CTNNB1 and Hepatocellular Carcinoma
|
| SPARC (
ON
, OSN
, BM-40
)
| 5q31.3-q32
|
-SPARC Over-expression in Hepatocellular Carcinoma
|
| HFE (
HLA-H
)
| 6p21.3
|
-HFE Mutations in Hepatocellular Carcinoma
|
| MET (
HGFR
, c-met
)
| 7q31
|
-MET and Hepatocellular Carcinoma
-MET and Childhood Hepatocellular Carcinoma
|
| DLC1 | 8p22-p21.3
|
-DLC1 and Hepatocellular Carcinoma
|
| MGMT | 10q26
|
-MGMT and Hepatocellular Carcinma
|
| KAI1 (
CD82
, R2
, ST6
)
| 11p11.2
|
-KAI1 and Hepatocellular Carcinoma
|
| CDKN1C (
KIP2
, P57
)
| 11p15.5
|
-CDKN1C Expression in Hepatocarcinoma
|
| IGF2 | 11p15.5
|
-IGF2 Expression in Hepatocarcinoma
|
| SLC22A1L (
BWSCR1A
, ORCTL2
, IMPT1
)
| 11p15.5
|
-SLC22A1L Expression in Hepatocarcinoma
|
| CD44 (
MDU3
, HA
, MDU2
)
| 11pter-p13
|
-CD99 Expression in Hepatocellular Carcinoma
|
| MMP12 (
HME
)
| 11q22.2-q22.3
|
-MMP12 Expression in Hepatocellular Carcinoma
|
| IGF1 | 12q22-q24.1
|
-IGF1 Expression in Hepatocellular Carcinoma
|
| AXIN1 | 16p13.3
|
-AXIN2 and Hepatocellular Carcinoma
|
| MMP2 (
CLG4A
, CLG4
, GELA
)
| 16q13
|
-MMP2 and Liver Cancer
|
| TP53 (
p53
, P53
)
| 17p13.1
|
-TP53 and Liver Cancer
|
| TIMP2 | 17q25
|
-TIMP2 and Liver Cancer
|
| BIRC5 (
survivin
, SVV
, API4
)
| 17q25(?)
|
-Survivin Expression in Hepatocellular Carcinoma
|
|
Hepatocelular Carcinoma: Clinical and Epidemiological Resources